Abstract:
The present invention relates to the novel diastereoselective syntheses for generating phosphorothioate compounds. Examples include nucleoside phosphorothioate analogs that are useful in treating diseases and/or conditions such as viral infections.
Abstract:
The present invention features processes for preparing compounds, such as (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2- (1 -hydroxy-2-methylpropan-2-yl)- 1H-indol-5 -yl)cyclopropanecarboxamide (Compound 1 ), useful for treating CFTR mediated diseases such as cystic fibrosis.
Abstract:
The present invention features processes for preparing compounds, such as (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2- (1 -hydroxy-2-methylpropan-2-yl)- 1H-indol-5 -yl)cyclopropanecarboxamide (Compound 1 ), useful for treating CFTR mediated diseases such as cystic fibrosis.
Abstract:
Un compuesto de fórmula (1) o una sal del mismo, en donde, independientemente, cada vez que aparecen: R² es -RJ, -ORJ, -N(RJ)₂, -NO₂, halógeno, -CN, -haloalquilo C₁₋₄, -haloalcoxi C₁₋₄, -C(O)N(RJ)₂, -NRJC(O)RJ, -SORJ, -SO₂RJ, -SO₂N(RJ)₂, -NRJSO₂RJ, -CORJ, -CO₂RJ, -NRJSO₂N(RJ)₂, o -COCORJ; RJ es hidrógeno o alifático C₁₋₆; R³ es alifático C₁₋₆ opcionalmente sustituido con OH, OP, -O-alifático C₁₋₆, arilo, heteroarilo, -O-arilo, u -O-heteroarilo; P es un grupo protector; y o es un entero de 0 a 3.
Abstract:
The present invention features processes for preparing compounds, such as (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2- (1 -hydroxy-2-methylpropan-2-yl)- 1H-indol-5 -yl)cyclopropanecarboxamide (Compound 1 ), useful for treating CFTR mediated diseases such as cystic fibrosis.
Abstract:
Disclosed herein is a method for preparing cycloalkylcarboxamido-indole compounds which are useful for treating CFTR mediated diseases such as cystic fibrosis. In particular a method of preparing a compound of formula I comprising the steps of: Reacting a compound of formula IA in a first organic solvent with a compound of formula IB; to form a compound of formula IC in the presence of a palladium catalyst; and Removing the –CO2RJ group from compound IC in a second organic solvent to form the compound of formula I.